English rendering of PM's speech during Nari Shakti Vandan Sammelan in New Delhi

India, April 13 -- The Government of India has issued a release: On the stage, Delhi's popular Chief Minister Smt. Rekha Gupta Ji, Union Minister Smt. Annapurna Devi Ji, Smt. Savitri Thakur Ji, Chair... Read More

PM to visit Uttarakhand and UP on 14 April

India, April 13 -- The Government of India has issued a release: Prime Minister Shri Narendra Modi, will visit Uttarakhand and Uttar Pradesh on 14 April 2026. At around 11:15 AM, the Prime Minister w... Read More

Prime Minister shares glimpses of his address at 'Nari Shakti Vandan Sammelan'

India, April 13 -- The Government of India has issued a release: Prime Minister Shri Narendra Modi, shared glimpses of his address at the 'Nari Shakti Vandan Sammelan' at Vigyan Bhawan, New Delhi tod... Read More

PRESIDENT OF INDIA GRACES CONVOCATION CEREMONY OF AIIMS RAJKOT

India, April 13 -- The Government of India has issued a release: The President of India, Smt Droupadi Murmu graced and addressed the first convocation ceremony of AIIMS Rajkot at Rajkot, Gujarat toda... Read More

PRESIDENT OF INDIA'S GREETINGS ON THE EVE OF BIRTH ANNIVERSARY OF DR. B.R. AMBEDKAR

India, April 13 -- The Government of India has issued a release: The President of India, Smt. Droupadi Murmu sends her greetings to fellow-citizens on the eve of the birth anniversary of Dr. B.R. Amb... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More

• ««
• «
• 1748
• 1749
• 1750
• 1751
• 1752
• 1753
• 1754
• 1755
• 1756
• 1757
• »
• »»